PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2105112
PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2105112
The dermatology devices market is valued at around USD 9.32 billion in 2026 and is expected to reach USD 17.73 billion by 2031, reflecting a CAGR of 13.7% over the forecast period. The rising prevalence of skin disorders, including skin cancer, acne, psoriasis, and pigmentation disorders, along with growing demand for minimally invasive and non-invasive aesthetic procedures, is driving adoption of advanced dermatology devices.
| Scope of the Report | |
|---|---|
| Years Considered for the Study | 2024-2031 |
| Base Year | 2025 |
| Forecast Period | 2026-2031 |
| Units Considered | Value (USD billion) |
| Segments | Type, Application, Technology, and End User |
| Regions covered | North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Ongoing advancements in laser, radiofrequency, HIFU, light-based, and imaging technologies are improving treatment precision, safety, and clinical outcomes, further supporting market growth. The growing aging population, increasing beauty consciousness influenced by social media, rising disposable incomes, and the expansion of dermatology clinics and aesthetic centers are also contributing to the adoption of dermatology devices worldwide.

"The imaging devices segment is expected to witness the fastest growth rate in the dermatology devices market, by diagnostic device type, during the forecast period."
Based on diagnostic device type, the dermatology devices market is segmented into imaging devices, dermatoscopes, and microscopes. During the forecast period, the imaging devices segment is expected to register the highest CAGR in the dermatology devices market. This growth is primarily driven by the increasing adoption of advanced, non-invasive imaging technologies for the early detection, diagnosis, and monitoring of skin disorders. The growing use of optical coherence tomography (OCT), high-frequency ultrasound (HFUS), and other high-resolution imaging systems enables real-time visualization of skin structures, improving diagnostic accuracy while reducing the need for invasive biopsies in many cases. Furthermore, continuous technological advancements, the rising incidence of skin cancer and other dermatological conditions, increasing demand for precise image-guided diagnosis, and growing adoption of advanced diagnostic technologies in dermatology clinics and hospitals are expected to drive rapid growth in this segment during the forecast period.
"The treatment devices segment accounted for the largest share of the dermatology devices market, by type, in 2025."
By type, the dermatology devices market is segmented into diagnostic and treatment devices. In 2025, the treatment devices segment accounted for the largest share of the dermatology devices market. This dominance is driven by rising demand for both aesthetic and therapeutic dermatology procedures, the growing prevalence of chronic and cosmetic skin conditions such as acne, psoriasis, skin cancer, and pigmentation disorders, and a growing preference for minimally invasive and non-invasive treatment options. Additionally, ongoing advances in laser, radiofrequency, HIFU, cryotherapy, and other energy-based technologies have improved treatment precision, safety, and clinical outcomes, leading to their widespread adoption. The expanding network of dermatology and cosmetic clinics, growing consumer awareness of aesthetic treatments, rising disposable incomes, and increasing acceptance of cosmetic procedures are further supporting the growth of the treatment devices segment.
"The Asia Pacific region is expected to witness the fastest growth in the dermatology devices market during the forecast period."
By region, the dermatology devices market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. During the forecast period, Asia Pacific is projected to register the highest CAGR in the dermatology devices market. This growth is primarily driven by rapid economic development, rising disposable incomes, and expanding access to healthcare across emerging economies such as China, India, Indonesia, and Thailand. The region's large and growing population, increasing prevalence of skin disorders, rising awareness of dermatological and aesthetic treatments, and growing demand for minimally invasive procedures further support market growth. Furthermore, the expanding middle-class population, increasing investments in healthcare infrastructure, rapid growth in dermatology and aesthetic clinics, continuous adoption of advanced dermatology technologies, and the growing popularity of medical tourism in countries such as South Korea and Thailand are expected to accelerate growth in the Asia Pacific dermatology devices market during the forecast period.
The key players in the dermatology devices market include Bausch Health Companies Inc. (Canada), Sisram Medical Ltd. (Israel), AbbVie Inc. (US), InMode Ltd. (Israel), BTL Group of Companies (Czech Republic), El.En. S.p.A. (Italy), Cutera, Inc. (US), Lumenis Be Ltd. (Israel), Cynosure Lutronic (US), Candela Corporation (US), Jeisys Medical Inc. (South Korea), HEINE Optotechnik GmbH & Co. KG (Germany), Canfield Scientific, Inc. (US), Michelson Diagnostics (UK), Genesis Biosystems, Inc. (US), FotoFinder Systems GmbH (Germany), Beijing Toplaser Technology Co., Ltd. (China), Aerolase (US), GIGAAMEDICAL (China), Dimed Laser (China), Sciton (US), Fotona (US), Lynton Lasers Ltd. (UK), Astanza Laser (US), and Courage+Khazaka electronic GmbH (Germany).
This research report categorizes the dermatology devices market by Type [Diagnostic Devices (Imaging Devices, Dermatoscopes, and Microscopes), Treatment Devices (Light Therapy Devices, Lasers, Electrosurgical Equipment, Liposuction Devices, Microdermabrasion Devices, Cryotherapy Devices, Radiofrequency Devices, and HIFU (High-Intensity Focused Ultrasound) Devices)], by Application [Diagnostic Applications (Skin Cancer Diagnosis, Inflammatory Skin Disease Diagnosis, Hair & Scalp Disorder Diagnosis, and Other Diagnostic Applications), Medical Therapeutic Applications (Skin Cancer Treatment, Acne & Psoriasis Treatment, Vascular & Pigmented Lesion Treatment, and Other Medical Therapeutic Applications), and Aesthetic Therapeutic Applications (Hair Removal, Skin Rejuvenation & Anti-aging, Wrinkle Removal & Skin Resurfacing, Body Contouring & Fat Removal, Tattoo Removal, and Other Aesthetic Therapeutic Applications)], by Technology (Laser-Based, Ultrasound-Based, Light-Based, Cryotherapy-Based, RF-Based, and Other Technologies), by End User (Hospitals, Dermatology Clinics & Medical Facilities, Beauty Centers, and Home Care Settings), and by Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa). The report provides a comprehensive overview of the key drivers, restraints, opportunities, and challenges shaping growth in the dermatology devices market. It offers an in-depth analysis of the major industry players, highlighting their business models, solutions, key strategies, recent acquisitions, and agreements. Additionally, the report includes a competitive analysis of emerging startups in the dermatology devices market.
The report will assist market leaders and new entrants in the dermatology devices industry by providing estimated revenue figures for the overall market and its subsegments. It aims to help stakeholders understand the competitive landscape, enabling them to position their businesses more effectively and develop appropriate go-to-market strategies. Additionally, the report offers insights into market dynamics, including key drivers, restraints, opportunities, and challenges.